INTERNATIONAL PATENT: XENON PHARMACEUTICALS INC. FILES APPLICATION FOR "AZETUKALNER FOR USE IN THE TREATMENT OF DEPRESSION, ANHEDONIA OR A SEIZURE DISORDER SUCH AS EPILEPSY IN PEDIATRIC SUBJECTS"

GENEVA, Sept. 3 -- XENON PHARMACEUTICALS INC. (3650 Gilmore WayBurnaby, BC V5G 4W8) filed a patent application (PCT/US2025/016769) for "AZETUKALNER FOR USE IN THE TREATMENT OF DEPRESSION, ANHEDONIA OR A SEIZURE DISORDER SUCH AS EPILEPSY IN PEDIATRIC SUBJECTS" on Feb 21, 2025. With publication no. WO/2025/179128, the details related to the patent application was published on Aug 28, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): FORGACS, Peter, Bertalan (C/o Xenon Pharmaceuticals Inc.3650 Gilmore WayBurnaby, BC V5G 4W8), BEATCH, Gregory, N. (C/o Xenon Pharmaceuticals Inc.3650 Gilmore WayBurn...